Diffuse Melanosis Cutis in the Era of Targeted Therapy
Keywords:
melanoma, target therapy, hyperpigmentation, metastatic melanoma, pdl-1References
Minocha R, Kefford R, Uribe P, et al. Diffuse melanosis cutis in the setting of BRAF V600E mutant melanoma and treatment with targeted therapies: DMC treated with targeted therapies. Australas J Dermatol. 2015;56(2):128–30.
Sebaratnam DF, Venugopal SS, Frew JW, McMillan JR, et al. Diffuse melanosis cutis: A systematic review of the literature. J Am Acad Dermatol. Mar;68(3):482–8.
Piana S, Longo C. Diffuse Melanosis and Melanuria. N Engl J Med. 2019 21;380(12):1166–1166.
Chinai B, Piazza M, Patel R, Roy S. Diffuse melanosis cutis: a rare manifestation of metastatic melanoma. BMJ Case Rep. 2019 30;12(8):e230396.
Fields K, Milikowski C, Jewell T, Fields J. Localized diffuse melanosis associated with melanoma successfully treated with imiquimod cream 5%: a case report and review of the literature. Cutis. 2014;93(3):145–50.
Sebaratnam DF, Martin LK, Venugopal SS, Mangos G, et al. Diffuse melanosis cutis in the setting of BRAF(V600E) metastatic melanoma. Int J Dermatol. 2014;53(11):1409–11.
Published
Issue
Section
License
Copyright (c) 2023 Fernanda Luiza Staub, Bruna Ossanai Schoenardie, Renan Rangel Bonamigo, Juliano Peruzzo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
